Uworld RxPrep: Sickle Cell Disease

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

38 Terms

1
New cards

What is the shape and lifespan of a normal adult red blood cell (RBC), and what type of hemoglobin does it contain?

Shaped like a donut without a hole, flexible enough to move through large and small blood vessels, contains adult hemoglobin (HbA), and has a lifespan of ~120 days.

2
New cards

What causes Sickle Cell Disease (SCD), and which population does it most commonly affect?

It is an inherited RBC disorder caused by a single genetic point mutation (nucleotide substitution) in the genes that encode hemoglobin. It most commonly affects the African American population.

3
New cards

What defines patients who are homozygous for the sickle cell gene?

They have two copies of the mutated gene and a high percentage (≥ 90%) of RBCs containing abnormal hemoglobin, called hemoglobin S (HbS) or sickle hemoglobin.

4
New cards

What happens to HbS molecules under deoxygenated conditions, and what are the consequences for the RBCs?

HbS molecules aggregate to form large polymers (polymerization). This makes RBCs rigid with a concave "sickle" shape, impairs oxygen transport, causes cells to stick together and block smaller blood vessels (vascular occlusion), and shortens their lifespan to 10–20 days due to hemolysis (causing anemia).

5
New cards

When do symptoms of SCD typically develop, and why are they delayed after birth?

Symptoms develop ~2–3 months after birth. Fetuses and young infants have high concentrations of fetal hemoglobin (HbF), which minimizes RBC sickling and masks symptoms.

6
New cards

How is SCD diagnosed in newborns versus older individuals?

Universal newborn screening is used for early recognition. In older individuals, diagnosis is confirmed via a hemoglobin electrophoresis test or high-performance liquid chromatography (HPLC), which measure HbA, HbF, and HbS levels.

7
New cards

What causes tissue ischemia in SCD, and where does acute pain most commonly occur?

Vascular occlusion prevents oxygen from reaching tissues, causing ischemia. Acute pain (vaso-occlusive crisis) lasts days or weeks and most commonly occurs in the lower back, legs, hips, abdomen, and chest.

8
New cards

What is Acute Chest Syndrome (ACS), and why is it clinically significant?

Chest pain accompanied by evidence of a pulmonary infection. It is life-threatening and is the leading cause of death in patients with SCD.

9
New cards

Which contraception methods are recommended and contraindicated for females with SCD?

Estrogen should be avoided due to the risk of stroke. Progestin-only contraceptives, levonorgestrel intrauterine devices (IUDs), and barrier methods are preferred.

10
New cards

What are the acute complications of Sickle Cell Disease?

Acute chest syndrome, severe anemia, cholecystitis (gallbladder infection), infection, multiorgan failure (kidneys, liver, lung), priapism (painful and prolonged erection), splenic sequestration, stroke, and vaso-occlusive crisis (acute pain episodes).

11
New cards

What are the chronic complications of Sickle Cell Disease?

Avascular necrosis (bone death), depression and stress, gallstones, leg ulcers, pain, pregnancy complications (including fetal death), pulmonary hypertension, recurrent priapism, renal impairment, and retinopathy.

12
New cards

How is mild to moderate acute SCD pain managed at home?

Rest, fluids, warm compresses applied to affected areas, and NSAIDs or acetaminophen.

13
New cards

What is the protocol for managing acute SCD pain in an emergency hospital setting?

Management is guided by self-reported pain severity; the outpatient pain regimen should be reviewed, and an analgesic administered within 30 minutes of triage. Severe pain requires IV opioids or patient-controlled analgesia (PCA).

14
New cards

What are the normal physiologic roles of a healthy spleen?

Removing old or damaged RBCs, aiding immune function by making and storing white blood cells, and clearing bacterial pathogens from the body—particularly encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis).

15
New cards

What happens to the spleen in patients with Sickle Cell Disease (SCD), and when does this typically occur?

Repetitive sickling and infarctions cause the spleen to become fibrotic and shrink in size, leading to functional asplenia (decreased or absent spleen function), typically within the first year of life.

16
New cards

Which pathogens pose a high risk of serious infection (e.g., sepsis, meningitis) in SCD patients with functional asplenia?

Encapsulated organisms (S. pneumoniae, H. influenzae, N. meningitidis), Salmonella spp., and atypical pathogens (Chlamydophila and Mycoplasma pneumoniae).

17
New cards

What should SCD patients do if they develop a fever, and why is it critical?

Seek immediate medical attention; infections are a major cause of death, especially in children < 5 years of age.

18
New cards

What is the prophylactic oral penicillin regimen for infants who screen positive for SCD at birth?

Penicillin taken twice daily until age five years. If an invasive pneumococcal infection develops despite prophylaxis, penicillin should be continued indefinitely.

19
New cards

What are the key vaccines recommended for patients with Sickle Cell Disease?

Haemophilus influenzae type B (Hib) (single dose if not given in childhood series); Pneumococcal conjugate vaccine (PCV): PCV20 (Prevnar 20), PCV21 (Capvaxive), or PCV15 (Vaxneuvance) x 1 followed by PPSV23 (Pneumovax 23) ≥ 8 weeks later; Meningococcal conjugate vaccine (MenACWY) series (starting at age ≥ 2 months) plus routine boosters (Menveo, MenQuadfi); Meningococcal serogroup B vaccine (MenB) series (starting at age ≥ 10 years) plus routine boosters (Bexsero, Trumenba).

20
New cards

What are the curative treatments for SCD, and why are they not widely used?

Bone marrow transplantation and autologous stem cell-based gene therapy; they are limited by safety risks and high costs compared to disease-modifying treatments (blood transfusion therapy and hydroxyurea).

21
New cards

What are the clinical uses of blood transfusions in SCD?

Chronic, prophylactic transfusions prevent vaso-occlusive complications and associated morbidity. Transfusions are also used to treat acute complications such as stroke, acute chest syndrome, and severe anemia.

22
New cards

How do blood transfusions reduce HbS concentrations in patients with SCD?

They provide RBCs containing normal adult hemoglobin (HbA), which decreases HbS levels via dilution and by reducing erythropoiesis (the formation of new RBCs containing HbS) due to the longer lifespan of HbA RBCs.

23
New cards

What is a major risk of chronic blood transfusion therapy, and what condition can it cause?

Iron overload, which can lead to hemosiderosis (excess iron that deposits in and damages organs such as the liver and heart).

24
New cards

How is excess iron removed from the body in SCD patients, and which oral medications are commonly used?

Chelation therapy. Commonly used oral chelating drugs include deferasirox (Exjade, Jadenu) and deferiprone (Ferriprox). Due to their side effect profiles, treatment is typically prescribed, dispensed, and monitored by specialty clinics and pharmacies.

25
New cards

What is the mechanism of action of hydroxyurea in Sickle Cell Disease?

It stimulates the production of fetal hemoglobin (HbF), which reduces relative HbS concentrations and results in less polymerization, vascular occlusions, and hemolysis.

26
New cards

What are the clinical benefits of long-term hydroxyurea therapy?

As a preventative medication (with benefits apparent after weeks or months), it reduces the frequency of acute pain episodes, the risk of acute chest syndrome, and the need for blood transfusions.

27
New cards

Which SCD patients are recommended to receive hydroxyurea?

All pediatric patients aged 9 months–18 years (regardless of disease severity), and all adults with ≥ 1 episode of moderate-severe pain or acute chest syndrome, or if chronic pain affects their quality of life.

28
New cards

What are the brand names and available dosage forms of hydroxyurea?

Brand names: Droxia, Siklos, Xromi. Dosage forms: Capsule, tablet, and oral solution.

29
New cards

What are the Boxed Warnings and general Warnings for hydroxyurea?

Boxed Warnings: Myelosuppression (↓ WBCs and platelets) and malignancy (leukemia, skin cancer). Warnings: Fetal toxicity, avoid live vaccines, macrocytosis, skin ulcers, and pulmonary toxicity.

30
New cards

What are the common side effects of hydroxyurea?

↑ LFTs, uric acid, BUN, and SCr; N/V/D; alopecia; atrophy or hyperpigmentation of skin and nails; and low sperm counts.

31
New cards

How is CBC monitored during hydroxyurea therapy, and when should the drug be held?

Check CBC with differential at baseline, every 2–4 weeks during initiation and dose titration, and every 2–3 months once a stable dose is achieved. Hold hydroxyurea if toxicity occurs (ANC < 2,000 cells/mm³ or platelets < 80,000 cells/mm³) until bone marrow recovers, then restart at a lower dose.

32
New cards

What other lab/clinical parameters must be monitored or adjusted for hydroxyurea?

Monitor HbF levels and obtain a baseline pregnancy test. For renal function, decrease the starting dose by 50% if CrCl < 60 mL/min.

33
New cards

What are the key counseling points and handling precautions for hydroxyurea?

Contraception is required for both males and females during treatment and for 6–12 months after discontinuation; do not breastfeed during treatment. It is a hazardous drug—wear gloves when dispensing and wash hands before and after contact. Folic acid supplementation is recommended.

34
New cards

What is the general role of L-glutamine and crizanlizumab in treating Sickle Cell Disease (SCD)?

They reduce complications associated with SCD and can be used as an adjunct to hydroxyurea or as alternative therapy in patients unable to tolerate hydroxyurea.

35
New cards

What is L-glutamine's mechanism of action, and how is it administered?

It is an amino acid thought to decrease oxidative stress (which promotes RBC sickling and hemolysis). It comes as an oral powder that can be mixed with 8 oz. of liquid (e.g., water, milk, apple juice) or 4–6 oz. of food (e.g., applesauce, yogurt).

36
New cards

What is crizanlizumab's mechanism of action, route of administration, and primary adverse reaction?

It is a monoclonal antibody that binds and inhibits P-selectin (a substance involved in the adhesion of sickled RBCs to vascular endothelium). It is administered as an IV infusion and can cause infusion-related reactions.

37
New cards

What are the key patient counseling points for handling hydroxyurea safely?

Wear disposable gloves while handling the medication to reduce exposure, wash hands before and after handling, and do not open the capsules.

38
New cards

What are the key clinical and reproductive counseling points for patients taking hydroxyurea?

It can cause infections. Avoid during pregnancy (teratogenic); effective contraception is required during and after treatment for sexually active males and females of reproductive potential. Avoid live vaccines, and check with a provider before getting any vaccines